BCL2 and cancer: ALF-Se NPs showed a significant selectivity impact (> 64) against alltreated cancer cells at IC50 63.10 ≤ μg/mL, as well as thestrongest upregulation of p53 and suppression of Bcl-2, MMP-9, and VEGF genes.